23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › DiaMedica Therapeutics Inc. › 2025-2026

DiaMedica Therapeutics Inc. 2025-2026 Proxy Voting Records

At DiaMedica Therapeutics Inc.'s shareholder meeting held May 20, 2026, in the 2025-2026 proxy season, 87 asset managers reported how they voted in their SEC Form N-PX filings, covering 867 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. DiaMedica Therapeutics Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on an advisory (non-binding) basis, executive compensation. — the reporting funds and managers cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and DiaMedica Therapeutics Inc.’s Form 8-K, filed May 21, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 10Reported items
  • 87Asset managers
  • 867Fund votes
  • May 20, 2026Meeting date

Results at a glance

Meeting of May 20, 2026: 10 items on DiaMedica Therapeutics Inc.’s Form 8-K, filed May 21, 2026: 7 elected · 3 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore DiaMedica Therapeutics Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by DiaMedica Therapeutics Inc.

These tallies are DiaMedica Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

DiaMedica Therapeutics Inc. — official shareholder meeting results, meeting held May 20, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Michael Giuffre, M.D. 10,119,610---- 229,02711,180,693 98%Elected—
Elect Director: Rick Kuntz, M.D., M.Sc. 10,166,733---- 181,90411,180,693 98%Elected—
Elect Director: Tanya Lewis 10,136,190---- 212,44711,180,693 98%Elected—
Elect Director: Daniel O'Connor 5,217,758---- 5,130,87911,180,693 50.4%Elected—
Elect Director: James Parsons 10,035,604---- 313,03311,180,693 97%Elected—
Elect Director: Rick Pauls 10,178,755---- 169,88211,180,693 98%Elected—
Elect Director: Charles Semba, M.D. 10,161,380---- 187,25711,180,693 98%Elected—
Voting Proposal 20,950,404---- 578,9260 97%Approved—
Voting Proposal 9,928,381271,093149,163 --11,180,693 97%Approved—
Voting Proposal 9,693,413510,487144,737 --11,180,693 95%Approved—

Source: DiaMedica Therapeutics Inc., Form 8-K, filed with the SEC on May 21, 2026 — read the filing on EDGAR.

How asset managers voted at the DiaMedica Therapeutics Inc. 2025-2026 meeting

Each item below shows how the 87 asset managers that disclosed a DiaMedica Therapeutics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DiaMedica Therapeutics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Charles Semba, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 10,161,380WITHHELD: 187,257
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Charles Semba, M.D.

DiaMedica Therapeutics Inc.’s own tally for this item (“Elect Director: Charles Semba, M.D.”): 10,161,380 for, 187,257 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results of each voting proposal brought before a vote of the Company's shareholders at the 2026 AGM are set forth below: Voting Proposal One - Election of Directors The seven director nominees, all incumbent directors, proposed by the Board were re-elected to serve as members of th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,054,730 for, 283 withheld.

FOR
FOR: 1,054,730WITHHOLD: 283
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,1830 0150For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA2,8750 00For
Calvert2,6970 00For
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

2. Elect Director: Daniel O'Connor

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

50.4% Majority: yes · of votes cast

FOR 50.4%WITHHELD
FOR: 5,217,758WITHHELD: 5,130,879
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Daniel J. O'Connor

DiaMedica Therapeutics Inc.’s own tally for this item (“Elect Director: Daniel O'Connor”): 5,217,758 for, 5,130,879 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results of each voting proposal brought before a vote of the Company's shareholders at the 2026 AGM are set forth below: Voting Proposal One - Election of Directors The seven director nominees, all incumbent directors, proposed by the Board were re-elected to serve as members of th…”
Support: 50.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,049,440 for, 5,572 withheld, 1 abstained.

FOR
FOR: 1,049,440ABSTAIN: 1WITHHOLD: 5,572
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,3320 10For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA00 02,875Withhold
Calvert00 02,697Withhold
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

3. Elect Director: James Parsons

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 10,035,604WITHHELD: 313,033
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: James Parsons

DiaMedica Therapeutics Inc.’s own tally for this item (“Elect Director: James Parsons”): 10,035,604 for, 313,033 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results of each voting proposal brought before a vote of the Company's shareholders at the 2026 AGM are set forth below: Voting Proposal One - Election of Directors The seven director nominees, all incumbent directors, proposed by the Board were re-elected to serve as members of th…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 935,084 for, 119,929 withheld.

FOR
FOR: 935,084WITHHOLD: 119,929
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab00 088,421Withhold
Vanguard75,2630 070For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X00 016,037Withhold
Pacific Life12,5750 00For
SEI00 09,900Withhold
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA2,8750 00For
Calvert00 02,697Withhold
Venerable Variable Insurance Trust00 02,671Withhold
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

4. Elect Director: Michael Giuffre, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 10,119,610WITHHELD: 229,027
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Michael Giuffre, M.D.

DiaMedica Therapeutics Inc.’s own tally for this item (“Elect Director: Michael Giuffre, M.D.”): 10,119,610 for, 229,027 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results of each voting proposal brought before a vote of the Company's shareholders at the 2026 AGM are set forth below: Voting Proposal One - Election of Directors The seven director nominees, all incumbent directors, proposed by the Board were re-elected to serve as members of th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,047,818 for, 7,195 withheld.

FOR
FOR: 1,047,818WITHHOLD: 7,195
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,1830 0150For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable17,8390 01,340Mixed
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA00 02,875Withhold
Calvert00 02,697Withhold
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

5. To elect seven persons to serve as directors until our next Annual General Meeting of…: Richard Kuntz, M.D., M.Sc.

No official matchDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Richard Kuntz, M.D., M.Sc.

The 31 asset managers below reported 1,055,013 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 1,055,013
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,3330 00For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA2,8750 00For
Calvert2,6970 00For
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

6. Elect Director: Rick Pauls

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 10,178,755WITHHELD: 169,882
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Rick Pauls

DiaMedica Therapeutics Inc.’s own tally for this item (“Elect Director: Rick Pauls”): 10,178,755 for, 169,882 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results of each voting proposal brought before a vote of the Company's shareholders at the 2026 AGM are set forth below: Voting Proposal One - Election of Directors The seven director nominees, all incumbent directors, proposed by the Board were re-elected to serve as members of th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,054,730 for, 283 withheld.

FOR
FOR: 1,054,730WITHHOLD: 283
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,1830 0150For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA2,8750 00For
Calvert2,6970 00For
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

7. Elect Director: Tanya Lewis

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 10,136,190WITHHELD: 212,447
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Tanya N. Lewis

DiaMedica Therapeutics Inc.’s own tally for this item (“Elect Director: Tanya Lewis”): 10,136,190 for, 212,447 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results of each voting proposal brought before a vote of the Company's shareholders at the 2026 AGM are set forth below: Voting Proposal One - Election of Directors The seven director nominees, all incumbent directors, proposed by the Board were re-elected to serve as members of th…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,049,441 for, 5,572 withheld.

FOR
FOR: 1,049,441WITHHOLD: 5,572
Largest asset managers voting on “To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until th” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,3330 00For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA00 02,875Withhold
Calvert00 02,697Withhold
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

8. To approve an amendment and restatement of the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive…

No official matchCOMPENSATION

Combines 2 wordings of this item as funds reported it.

97% of fund votes cast · no official result

FOR
Details: description as filed, votes by 31 asset managers

Description as filed by funds: To approve an amendment and restatement of the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan.

The 31 asset managers below reported 1,028,437 for, 26,576 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 1,028,437AGAINST: 26,576
Largest asset managers voting on “To approve an amendment and restatement of the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus I” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,183150 00For
Jacob Funds Inc.66,9300 00For
Lincoln Financial020,900 00Against
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street03,745 00Against
TIAA2,8750 00For
Calvert2,6970 00For
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

9. To approve, on an advisory (non-binding) basis, executive compensation.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 87 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 31 asset managers voting on “To approve, on an advisory (non-binding) basis, executive compensation.” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,3330 00For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco06,189 00Against
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA2,8750 00For
Calvert2,6970 00For
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Fund voting reports, all 31 managers: 1,048,691 for, 6,322 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 68 asset managers voting on “To approve, on an advisory (non-binding) basis, executive compensation.” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST MANHATTAN CO. LLC.455,0000 00For
GEODE CAPITAL MANAGEMENT, LLC418,1810 00For
Bleichroeder LP382,3170 00For
State Street234,991833 00For
BlackRock201,03617,074 00Mixed
Northern Trust207,0861,087 00For
Vanguard144,3140 00For
Charles Schwab88,4210 00For
Private Capital Management, LLC50,0000 00For
MELLON INVESTMENTS Corp49,9860 00For
T. Rowe Price38,9120 00For
Informed Momentum Co LLC36,5920 00For
BANK OF MONTREAL /CAN/22,8850 00For
RBC Capital Markets, LLC22,5000 00For
Invesco019,833 00Against
Stonebridge Capital Advisors LLC17,5000 00For
Corient Private Wealth LP17,1000 00For
JPMorgan13,9510 00For
SEI9,9000 00For
Perigon Wealth Management, LLC9,7000 00For
Goldman Sachs7,8580 00For
MetLife Investment Management, LLC7,0080 00For
Voya5,6880 00For
MassMutual4,8240 00For
Prudential/PGIM4,7050 00For

Institutional-manager reports, all 68 managers: 2,520,963 for, 45,813 against. Showing the 25 largest; every one is in the interactive database (link above).

10. To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal…

No official matchAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 31 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF BAKER TILLY US, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

The 31 asset managers below reported 1,055,013 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 1,055,013
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF BAKER TILLY US, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE ” at DiaMedica Therapeutics Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock343,8460 00For
Fidelity332,8130 00For
Charles Schwab88,4210 00For
Vanguard75,3330 00For
Jacob Funds Inc.66,9300 00For
Lincoln Financial20,9000 00For
Equitable19,1790 00For
Global X16,0370 00For
Pacific Life12,5750 00For
SEI9,9000 00For
Goldman Sachs7,8360 00For
Bridge Builder Trust6,4970 00For
Invesco6,1890 00For
Voya5,6880 00For
ProShares5,5500 00For
Nationwide4,9180 00For
Brighthouse4,8550 00For
AIG/SunAmerica4,6200 00For
John Hancock4,5750 00For
State Street3,7450 00For
TIAA2,8750 00For
Calvert2,6970 00For
Venerable Variable Insurance Trust2,6710 00For
Principal2,5470 00For
Northern Trust1,6540 00For

Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).

Largest DiaMedica Therapeutics Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 53,883,345 shares outstanding at the time of that meeting.

Fund voting reports: top DiaMedica Therapeutics Inc. shareholders by shares voted on “To approve, on an advisory (non-binding) basis, executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 0.64%
2Fidelity 0.62%
3Charles Schwab 0.16%
4Vanguard 0.14%
5Jacob Funds Inc. 0.12%
6Lincoln Financial 0.04%
7Equitable 0.04%
8Global X 0.03%
9Pacific Life 0.02%
10SEI 0.02%
Institutional-manager reports: top DiaMedica Therapeutics Inc. shareholders by shares voted on “To approve, on an advisory (non-binding) basis, executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1FIRST MANHATTAN CO. LLC. 0.84%
2GEODE CAPITAL MANAGEMENT, LLC 0.78%
3Bleichroeder LP 0.71%
4State Street 0.44%
5BlackRock 0.40%
6Northern Trust 0.39%
7Vanguard 0.27%
8Charles Schwab 0.16%
9Private Capital Management, LLC 0.09%
10MELLON INVESTMENTS Corp 0.09%

Reported DiaMedica Therapeutics Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

DiaMedica Therapeutics Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
TRILL AB 16.38% 13G
Cooperman Leon G. 6.40% 13G
BlackRock 3.44% 13F
Millennium Management 1.74% 13F
Geode Capital 1.45% 13F
Vanguard Group 1.34% 13F
State Street 1.20% 13F
Morgan Stanley 1.02% 13F
Northern Trust 0.63% 13F
Citadel Advisors 0.32% 13F

Percentages above are of 53,883,345 shares outstanding, as reported by DiaMedica Therapeutics Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DiaMedica Therapeutics Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

DiaMedica Therapeutics Inc. proxy season coverage: 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “DiaMedica Therapeutics (DMAC) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/diamedica-therapeutics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.